Functional outcome after delivery of intrathecal baclofen

B. Parke, R. D. Penn, S. M. Savoy, D. Corcos

Research output: Contribution to journalArticlepeer-review

75 Scopus citations


Patients with multiple sclerosis or spinal cord injury often have severe, disabling spasticity. This is frequently treated with oral medications or with destructive neurosurgical procedures. We report on a group of patients with spasticity not relieved by these methods. These patients were subsequently treated with intrathecal baclofen delivered by an implanted programmable drug pump. Twenty-one patients have received this form of treatment, and the functional status of eight has been tracked by the Patient Evaluation Conference System (PECS) for at least six months. In most cases, spasticity, performance of bowel and bladder programs, and performance of ADL improved after delivery of intrathecal baclofen. The improvements appear to be due to the decrease in hypertonicity and the increased ease of movement (passive or active) in affected extremities. Intrathecal baclofen should be considered as a treatment method in patients with severe spasticity of spinal origin.

Original languageEnglish (US)
Pages (from-to)30-32
Number of pages3
JournalArchives of physical medicine and rehabilitation
Issue number1
StatePublished - 1989

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation


Dive into the research topics of 'Functional outcome after delivery of intrathecal baclofen'. Together they form a unique fingerprint.

Cite this